Existing treatments for fibromyalgia have limited efficacy. The post Tryp Looks at Patent for Psilocybin to Treat Fibromyalgia appeared first on Green...
Core One Labs Inc. (CSE:COOL), (OTCQB:CLABF), (Frankfurt:LD6, WKN:A3CSSU) is pleased to announce it has entered into a Letter of Intent with Medelys Laboratories...
The article HAVN Life Shutting Down? was originally published on Microdose. Unfortunate news for investors in HAVN Life Sciences as it seems the company...
Havn said it is actively seeking new funding, but it might not be successful. The post Havn Life Sciences Faces Bankruptcy, Cash Crunch Cuts Runway appeared...
XPhyto Therapeutics Corp. (CSE:XPHY | OTCQB:XPHYF | FSE:4XT) is pleased to report that it has filed a patent application for a significant library of...
Tryp Therapeutics Inc. (CSE: TRYP), a clinical-stage biotechnology company focused on developing psilocybin-based compounds for diseases with unmet medical...
Psyence Group Inc. (CSE: PSYG | OTCQB: PSYGF), a life science biotechnology company pioneering the use of natural psychedelics in mental health and well-being,...
Core One Labs Inc. (CSE:COOL | OTCQB:CLABF | Frankfurt:LD6, WKN:A3CSSU) is pleased to announce that following the receipt of very positive results during...
PharmaTher Holdings Ltd. (OTCQB: PHRRF | CSE: PHRM), a leader in specialty ketamine pharmaceuticals, today announced that the Phase 1/2 clinical Study...
Oral psilocybin film-strips to treat could conduct the first-in-human clinical study as soon as next year. The post Revive Therapeutics Gets Nod From FDA,...